A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Project: Research

Short title	233AS303
Status	Not started

Access Project

CRG endorsement_ subject to conditions_MQCRG2021038_Rowe
File: application/pdf, 223 KB
Type: Other
DRAFT_BIOGEN_233AS303_ATLAS_Budget_Macquarie University_01Jun2021_RG
File: application/vnd.openxmlformats-officedocument.spreadsheetml.sheet, 151 KB
Type: Budget
233AS303_Certificate of Insurance_Australia_12Nov2020
File: application/pdf, 118 KB
Type: Other
Biogen_233AS303_MQ_09Jun2021_DRAFT_TC - MQ Edits - 22.6.2021
File: application/msword, 633 KB
Type: Legal/Contracts Advice
HREC Approval
File: application/pdf, 144 KB
Type: Award letter